BridgeBio Pharma, Inc. (BBIO) Autosomal Dominant Hypocalcemia Type 1 (ADH1) Investor Webinar Call (Transcript)

PresentationThank you for standing by, and welcome to the Autosomal Dominant Hypocalcemia Type 1 investor webinar. [Operator Instructions] I'd now like to turn the call over to Ananth Sridhar. You may begin.Ananth Sridhar Thank you, operator, and good morning, everyone. We're pleased to have you join us as we provide a presentation to discuss encaleret, a small molecule that we're developing for autosomal dominant hypocalcemia type 1, abbreviated as ADH1 throughout this presentation. On our next slide, you' ...